Akorn Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AKORN, and what generic and branded alternatives to AKORN drugs are available?
AKORN has eighteen approved drugs.
There are two tentative approvals on AKORN drugs.
Summary for Akorn
US Patents: | 0 |
Tradenames: | 18 |
Ingredients: | 18 |
NDAs: | 18 |
Patent Litigation for Akorn: | See patent lawsuits for Akorn |
PTAB Cases with Akorn as petitioner: | See PTAB cases with Akorn as petitioner |
Drugs and US Patents for Akorn
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Akorn | SULFACETAMIDE SODIUM | sulfacetamide sodium | SOLUTION/DROPS;OPHTHALMIC | 040215-001 | May 25, 1999 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Akorn | TIMOLOL MALEATE | timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 074466-001 | Mar 25, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Akorn | DIPHENHYDRAMINE HYDROCHLORIDE | diphenhydramine hydrochloride | SYRUP;ORAL | 072416-001 | Sep 28, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.